Overview

Effects of Imatinib in Subjects With Seasonal Allergic Rhinitis and Who Are Sensitive to Timothy Grass Pollen

Status:
Completed
Trial end date:
2007-08-01
Target enrollment:
Participant gender:
Summary
This study will assess the effects of Imatinib on allergic inflammation following repeated nasal allergen challenge in subjects with seasonal allergic rhinitis sensitive to Timothy grass pollen.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Novartis
Treatments:
Imatinib Mesylate